Corrigé question 1 - Examen corrige
18.6 Insurance. 18.7 Modification of the protocol. 19 Study monitoring. 20
Appendices. 19 Appendix 1 SAE reporting form. 19 Appendix 2 Informed
Consent. 19 Appendix 3 ...... Erlotinib re-challenge after interruption of dosing will
occur only if the investigator considers it is in the best interest of the patient to re-
challenge.